CVS Health had another solid quarter. The company, which is emerging from a yearslong turnaround, reported an 8% increase in ...

Award recognizes WEI's strategic innovation, technical execution, and commitment to long-term partnership SALEM, NH / ...

CVS Health reported $2.9 billion in fourth quarter net income as the company begins to get a handle on costs that have hit ...

Feb 10 (Reuters) - CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped ...

CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

CVS Health’s rehabilitation efforts to return to full strength appear to be on track after a strong fourth quarter. The ...

Adjusted EPS: $1.09 (beat consensus of $1.00) GAAP EPS: $2.30 vs. $1.30 prior year (includes $1.9 billion tax benefit from subsidiary bankruptcy) Full-Year 2025 Revenue: $402.1 billion, up 7.8% Stock ...

CVS Health CEO David Joyner told investors on Tuesday that the recently proposed rates for the 2027 Medicare Advantage plan ...

CVS Health reported higher fourth-quarter and full-year revenues in 2025, driven by growth across its pharmacy, health ...

Medicare Advantage rates may not be going up as much as expected in 2027, and that has investors concerned about CVS Health.

CVS Health Corp. missed Wall Street’s profit projections for 2026, failing to clear the high bar the market set for the ...

CVS Health Corporation (NYSE:CVS) is one of the stocks in focus on Jim Cramer’s game plan. Cramer highlighted the stock’s ...